These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 782701)

  • 41. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of multiple myeloma using vincristine, cyclophosphamide, melphalan and prednisone (VCMP). Long-term results in 63 patients].
    Bladé J; Urbano A; López Guillermo A; Rozman M; Rovira M; Montserrat E; Rozman C
    Sangre (Barc); 1990 Apr; 35(2):93-7. PubMed ID: 2363100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conventional chemotherapy in multiple myeloma.
    Westin J
    Pathol Biol (Paris); 1999 Feb; 47(2):169-71. PubMed ID: 10192883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.
    Cornwell GG; Pajak TF; Kochwa S; McIntyre OR; Glowienka LP; Brunner K; Rafla S; Coleman M; Cooper MR; Henderson E
    J Clin Oncol; 1988 Sep; 6(9):1481-90. PubMed ID: 3047338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation.
    Kyle RA; Leong T; Li S; Oken MM; Kay NE; Van Ness B; Greipp PR
    Cancer; 2006 May; 106(9):1958-66. PubMed ID: 16565956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
    Alberts DS; Durie BG; Salmon SE
    Lancet; 1976 May; 1(7966):926-8. PubMed ID: 57335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases].
    Brun B; Kuentz M; Man NG; Feuilhade F; Bierling P; Vernant JP; Farcet JP; Cordonnier C; Reyes F; Dreyfus B; Rochant H
    Presse Med; 1983 Apr; 12(19):1205-10. PubMed ID: 6221296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
    Pouillart P; Mathé G; Poisson M; Buge A; Huguenin P; Gautier H; Morin P; Thy HT; Lheritier J; Parrot R
    Nouv Presse Med; 1976 Jun; 5(25):1571-6. PubMed ID: 778798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC; Lee DJ; Clarkson BD
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract]   [Full Text] [Related]  

  • 51. Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis.
    Hartman HA; Skoog D; Foley JF; Stone DB
    Nebr Med J; 1979 Jul; 64(7):201-5. PubMed ID: 112484
    [No Abstract]   [Full Text] [Related]  

  • 52. DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.
    Hill GJ; Metter GE; Krementz ET; Fletcher WS; Golomb FM; Ramirez G; Grage TB; Moss SE
    Cancer Treat Rep; 1979; 63(11-12):1989-92. PubMed ID: 393384
    [No Abstract]   [Full Text] [Related]  

  • 53. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease: its role in remission induction and maintenance.
    Anderson T; DeVita T; Young RC
    Cancer Treat Rep; 1976 Jun; 60(6):761-7. PubMed ID: 782698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current concepts in cancer. Multiple myeloma.
    McIntyre OR
    N Engl J Med; 1979 Jul; 301(4):193-6. PubMed ID: 377077
    [No Abstract]   [Full Text] [Related]  

  • 55. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL
    Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
    [No Abstract]   [Full Text] [Related]  

  • 56. Unmaintained remissions in multiple myeloma.
    Alexanian R; Gehan E; Haut A; Saiki J; Weick J
    Blood; 1978 Jun; 51(6):1005-11. PubMed ID: 647110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
    Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
    Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
    [No Abstract]   [Full Text] [Related]  

  • 58. A new basis for treatment of multiple myeloma.
    Salmon SE; Durie BG; Hamburger AW
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1568-72. PubMed ID: 694483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
    Buge A; Poisson M; Pouillart P
    Rev Neurol (Paris); 1978 May; 134(5):369-77. PubMed ID: 364592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
    Lee BJ; Sahakian G; Clarkson BD; Krakoff IH
    Cancer; 1974 Feb; 33(2):533-8. PubMed ID: 4812771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.